What role can disease foundations play in moving scientific discoveries from the lab toward meaningful solutions for patients?In this episode, host Elaine Hamm, PhD, sits down with Tim Coetzee, PhD, President and CEO of the National Multiple Sclerosis Society, to explore how disease foundations can help shape the research and innovation ecosystem. Tim shares the Society’s evolution from funding its first research grants nearly 80 years ago to connecting scientists, clinicians, policymakers,

Cardiovascular disease remains the world's leading cause of death, yet many patients still face substantial risks even after conventional factors such as LDL cholesterol and blood pressure are controlled. Rezera is developing its experimental therapy ruvonoflast, an NLRP3 inhibitor, to address this residual inflammatory risk. The therapy is designed to suppress chronic, tissue-based inflammation while preserving the immune system's ability to respond to infection. Rezera CEO Geoff McDonough

Save 20% on all Nuzest Products WORLDWIDE with the code MIKKIPEDIA at www.nuzest.co.nz, www.nuzest.com.au or www.nuzest.comEpisode SummaryPaul Booth, sports nutritionist, exercise physiologist and PhD researcher in ultra-running metabolism, is back on Mikkipedia, straight from UTMB week in Chamonix, where he raced OCC and worked with elite athletes. Mikki and Paul pick up where they left off a year ago, talking about how much carbohydrate trail and ultra runners actually need. Paul shares

The scarecrow watches over the field, but does it watch us back? Does it keep the birds away, or does it deter darker fiends from these haunted lands? Join Robert and Joe for a Halloween-season look at the science, culture and folklore of scarecrows.See omnystudio.com/listener for privacy information.

Michael speaks with Tim Wu, the Columbia law professor and author of The Age of Extraction, about how media and tech platforms learned to harvest our attention, why convenience is among the most powerful forces of our time, and what the easy option can take from us. They discuss:(00:00) Cold open(01:12) Selling attention, from 1833 to now(07:46) Why phones are changing human evolution(16:20) Why ads adapt to every backlash(18:00) Attention merchants vs. extractors(25:48) Easiest wins: the power of

You've perfected your process at the bench. Now comes the part that keeps CMC scientists up at night: will it still work at 2,000L? Right now, most teams find out the hard way, through failed runs, wasted batches, and months of delay to patients waiting on a therapy. Christian Witz believes there's a better way: use computational fluid dynamics to see how your cells will actually behave at full scale before you ever run the process, and stop treating scale-up as a guessing game. On this episo...

Pharma partnering in China is getting earlier and broader, with Merck & Co., Novo Nordisk and Novartis striking multibillion-dollar deals for assets spanning new modalities and disease areas. On the latest BioCentury This Week podcast, BioCentury's analysts assess the trend and why co-development deals could draw scrutiny in Washington. The analysts also discuss the complexities of Beam's trade secret suit against YolTech, why the GLOBE Medicare pricing model matters more for the preceden...

Welcome back to another episode of PASCV: Gone Viral!We return with part 2 of 2 of our tick-borne virus series with our hosts Kaisha & Saina, who are joined by Drs. Ryan Relich, Muhammad Morshed, and Kyle Rodino, as they continue their discussion on various tick-borne diseases, their expanding geographical range, and challenges with diagnostics, surveillance, and clinical impact. Interested in becoming a member of PASCV?https://www.pascv.org/general/register_member_type.aspCheck out our

In this classic episode of Weirdhouse Cinema, Rob and Joe discuss the 1988 horror comedy creature feature Killer Klowns From Outer Space, produced by the Chiodo brothers and starring Grant Cramer, Suzanne Snyder, John Allen Nelson and John Vernon. (originally published 10/3/2025)See omnystudio.com/listener for privacy information.

Dr. Beth Shapiro, PhD, is an evolutionary biologist and Chief Science Officer at Colossal Biosciences. Her work focuses on de-extinction and wildlife conservation efforts. We discuss genetic differences among humans, and how ancient DNA and modern embryology are being used to de-extinct and protect woolly mammoths, dodo birds, and dire wolves, as well as to help conserve endangered species. We also explore the ethical implications of de-extinction and how synthetic biology can help build a more bio

AI Success Foundations for Pharma 4.0Artificial intelligence has the potential to transform pharmaceutical R&D, manufacturing, quality, clinical development, and the broader healthcare value chain. But successful AI adoption in pharma does not begin with sophisticated algorithms—it begins with strong foundations. In this episode of Center of Excellence - Pharma 4.0, we explore the AI Success Foundation Framework for Pharma 4.0 and examine what pharmaceutical organizations need to establish

Bienvenidos a IMPACTO,Elsa Morales Roth conversa con  Rosa Olascoaga-Vidal, jefa de gabinete del Distrito 9 de la Ciudad de San Diego, sobre cómo una joven de City Heights se convirtió en una voz clave de las políticas públicas locales. Rosa empezó a organizarse a los 12 años, después de que un auto atropellara a su hermano mientras patinaba, y logró que se construyera un parque de patinaje en su comunidad con el apoyo de la Tony Hawk Foundation y The California Endowment. Cuenta también cómo, tras

In this episode, we sit down with Mark Olly: author, television presenter, archaeologist, musician, producer, artist, and public speaker. Known for his appearances on Ancient Aliens and his series Lost Treasures, Mark brings a real-life Indiana Jones spirit to exploring the past. His travels have taken him to some of the world’s most fascinating ancient sites—places that continue to inspire questions thousands of years later. From Egypt’s ancient landscapes to the mysteries of Chichén Itzá, M...

There’s a lot of current hype around AI, it’s abilities but also the potential threat that it poses to humanity. The standard narrative sounds like a sci-fi movie, one of these systems is on the verge of waking up and taking over the whole world and has been for at least the last five years. In this episode we take a skeptical look at AI, the current state of the art, the history and development of these systems, examples of AI outside of LLMs. And take a close look at the argument that AI is about

Episode SummaryThis month on the Deep-Sea Podcast, we speak with Anne Helene Tandberg, a researcher from the University Museum of Bergen who specializes in amphipods and curated the deep-sea exhibit at the University Museum of Bergen, Norway. Check out our lovely new website where you can find more detailed notes, images and links to the wider reading. In this episode… Welcome back to the Deep-Sea Podcast, your punk take on all things deep sea! Alan is living day 56 on a boat, and feeling

Get in touch to share sheeping stories or questions anytime! We love hearing from our listeners and in this episode we answer some interesting questions from listeners on routine hoof care for sheep and how and when to castrate lambs. Andrew recently attended the Irish Lanark society sale in Roscommon and his buying strategy paid off big time! Thanks for listening! Thank you for supporting our pod! Sign up via our sheep supporters tab ! https://www.buzzsprout.com/954910/supporter...

In this classic episode of Stuff to Blow Your Mind, Robert and Joe discuss the idea of Egyptian tomb curses, how they actually factored into ancient Egyptian practices and where the myth of the Pharaoh's curse meets reality. (originally published 9/30/2025)See omnystudio.com/listener for privacy information.

Business Creativity and Innovation in Pharma 4.0What happens when one of the world’s most highly regulated industries embraces creativity, experimentation, artificial intelligence, and digital technologies? In this episode of Center of Excellence - Pharma 4.0, we explore how business creativity and innovation can reshape the pharmaceutical industry—not by compromising scientific rigor or regulatory compliance, but by creating smarter, safer, faster, and more adaptive ways of working. The discussion

While falls can happen to anyone, older adults are more likely to experience serious injuries as a result. That's why falls prevention is an important public health issue for all of us, not just for older adults but also for their families, caregivers, and communities. In this episode, Dr. Carol Petrie, a board certified expert in geriatric physical therapy and falls prevention talks about the best ways to reduce our risk of falling, when we should begin thinking about it, advice for caregive...

Send us Fan Mail The 2026 Guideline for Adult Stroke Rehabilitation and Recovery from the American Heart Association and American Stroke Association is a major update to how we understand stroke rehabilitation, recovery, and long term care. This is a conversation about the evidence, the gaps, and what happens when stroke rehabilitation recommendations meet the people actually living them. In this episode of Brain Friends, Angie sits down with Dr. Lorie G. Richards, PhD, OTR/L, FAHA, occupatio...